Key Details
Price
$22.40Annual Revenue
$325.11 MAnnual EPS
-$0.43Annual ROE
-150.08%Beta
1.14Events Calendar
Next earnings date:
Feb 14, 2025Recent quarterly earnings:
Nov 06, 2024Recent annual earnings:
Feb 15, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Cellebrite Endpoint Inspector Solutions are now generally available within RelativityOne Cellebrite Endpoint Inspector Solutions are now generally available within RelativityOne
Investors looking for stocks in the Technology Services sector might want to consider either Nu Holdings Ltd. (NU) or Cellebrite DI Ltd.
I previously rated Cellebrite DI a 'strong buy' due to its growth potential and attractive valuation. Since my recommendation, Cellebrite has outperformed, with the stock rising 160% compared to the S&P 500's 33% increase. Cellebrite has positive developments from its Q3 2024 earnings report.
I maintain a neutral rating on Cellebrite due to its premium valuation and risks from CEO transition and potential federal budget cuts. Despite solid growth, including a 27% revenue increase and expanding margins, uncertainties around leadership and federal funding impact my outlook. Strong adoption of Inseyets, Guardian, and Pathfinder products, with notable ARR growth, suggests a long growth runway ahead.
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.11 per share.
Third- q uarter 2024 r evenue of $106.9 million exceeds $100 million quarterly revenue milestone for the first time in Company history
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024.
Cellebrite DI Ltd. (CLBT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the “Company” or “we”), a global leader in premier Digital Investigative solutions for the public and private sectors, announced today the results of the completed redemption (the “Redemption”) of its Warrants (as defined below) to purchase ordinary shares of the Company (the “Ordinary Shares”).
Pathfinder's capabilities are now available via the cloud, giving law enforcement new deployment options to accelerate justice
FAQ
- What is the primary business of Cellebrite DI?
- What is the ticker symbol for Cellebrite DI?
- Does Cellebrite DI pay dividends?
- What sector is Cellebrite DI in?
- What industry is Cellebrite DI in?
- What country is Cellebrite DI based in?
- When did Cellebrite DI go public?
- Is Cellebrite DI in the S&P 500?
- Is Cellebrite DI in the NASDAQ 100?
- Is Cellebrite DI in the Dow Jones?
- When was Cellebrite DI's last earnings report?
- When does Cellebrite DI report earnings?
- Should I buy Cellebrite DI stock now?